Friday, July 30, 2021

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business As a part of the transaction, Lupin will gain access to over 60 registered products having sales of over AUD 30 million

from Moneycontrol Business News https://ift.tt/3BWpqWx

No comments:

Post a Comment

Vikas Khemani on key triggers that will shape the market’s next big move

Most people kind of turned bearish on global concerns, oil prices. So, people tend to kind of extrapolate more bad news. So that has happene...